Unknown

Dataset Information

0

Fighting malaria with engineered symbiotic bacteria from vector mosquitoes.


ABSTRACT: The most vulnerable stages of Plasmodium development occur in the lumen of the mosquito midgut, a compartment shared with symbiotic bacteria. Here, we describe a strategy that uses symbiotic bacteria to deliver antimalaria effector molecules to the midgut lumen, thus rendering host mosquitoes refractory to malaria infection. The Escherichia coli hemolysin A secretion system was used to promote the secretion of a variety of anti-Plasmodium effector proteins by Pantoea agglomerans, a common mosquito symbiotic bacterium. These engineered P. agglomerans strains inhibited development of the human malaria parasite Plasmodium falciparum and rodent malaria parasite Plasmodium berghei by up to 98%. Significantly, the proportion of mosquitoes carrying parasites (prevalence) decreased by up to 84% for two of the effector molecules, scorpine, a potent antiplasmodial peptide and (EPIP)(4), four copies of Plasmodium enolase-plasminogen interaction peptide that prevents plasminogen binding to the ookinete surface. We demonstrate the use of an engineered symbiotic bacterium to interfere with the development of P. falciparum in the mosquito. These findings provide the foundation for the use of genetically modified symbiotic bacteria as a powerful tool to combat malaria.

SUBMITTER: Wang S 

PROVIDER: S-EPMC3412027 | biostudies-literature | 2012 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Fighting malaria with engineered symbiotic bacteria from vector mosquitoes.

Wang Sibao S   Ghosh Anil K AK   Bongio Nicholas N   Stebbings Kevin A KA   Lampe David J DJ   Jacobs-Lorena Marcelo M  

Proceedings of the National Academy of Sciences of the United States of America 20120716 31


The most vulnerable stages of Plasmodium development occur in the lumen of the mosquito midgut, a compartment shared with symbiotic bacteria. Here, we describe a strategy that uses symbiotic bacteria to deliver antimalaria effector molecules to the midgut lumen, thus rendering host mosquitoes refractory to malaria infection. The Escherichia coli hemolysin A secretion system was used to promote the secretion of a variety of anti-Plasmodium effector proteins by Pantoea agglomerans, a common mosqui  ...[more]

Similar Datasets

| S-EPMC8544976 | biostudies-literature
| S-EPMC1450296 | biostudies-literature
| S-EPMC3715529 | biostudies-literature
| S-EPMC9796203 | biostudies-literature
| S-EPMC3521722 | biostudies-literature
| S-EPMC4811326 | biostudies-literature
| S-EPMC9793889 | biostudies-literature
| S-EPMC10199888 | biostudies-literature
| S-EPMC6128571 | biostudies-literature
| S-EPMC11346999 | biostudies-literature